PRESS RELEASE
Australia's Therapeutic Goods Administration Approves SKY-0515 Clinical Trial
The TGA has approved the clinical trial application for SKY-0515 in Australia, supporting the global FALCON-HD Phase 2/3 trial expansion.
LEARN MORE →News
Latest news, press releases, and clinical updates from Skyhawk Therapeutics.
PRESS RELEASE
Skyhawk Announces Strategic Collaboration with Merck KGaA, Darmstadt, Germany
Skyhawk and Merck KGaA enter a multi-target collaboration to discover and develop RNA-targeted small molecule therapies across multiple therapeutic areas.
LEARN MORE →